Prathyusha Duraibabu

2021

In 2021, Prathyusha Duraibabu earned a total compensation of $1.1M as Senior Vice President, Chief Financial Officer at Sangamo Biosciences.

Compensation breakdown

Non-Equity Incentive Plan$127,439
Option Awards$319,108
Salary$362,586
Stock Awards$242,063
Other$5,554
Total$1,056,750

Duraibabu received $362.6K in salary, accounting for 34% of the total pay in 2021.

Duraibabu also received $127.4K in non-equity incentive plan, $319.1K in option awards, $242.1K in stock awards and $5.6K in other compensation.

Rankings

In 2021, Prathyusha Duraibabu's compensation ranked 8,615th out of 12,405 executives tracked by ExecPay. In other words, Duraibabu earned more than 30.6% of executives.

ClassificationRankingPercentile
All
8,615
out of 12,405
31st
Division
Manufacturing
3,818
out of 5,494
31st
Major group
Chemicals And Allied Products
1,690
out of 2,369
29th
Industry group
Drugs
1,504
out of 2,090
28th
Industry
Biological Products, Except Diagnostic Substances
329
out of 452
27th

Pay ratio

Prathyusha Duraibabu's Pay$1,056,750
Median Employee's Pay$170,218
Pay Ratio

6

to 1

In 2021, the annual total compensation of Prathyusha Duraibabu was $1,056,750.

The annual total compensation of the median employee at Sangamo Biosciences was $170,218.

The ratio of Prathyusha Duraibabu's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 1, 2022.

Duraibabu's colleagues

We found five more compensation records of executives who worked with Prathyusha Duraibabu at Sangamo Biosciences in 2021.

2021

Alexander Macrae

Sangamo Biosciences

Chief Executive Officer

2021

Robert Schott

Sangamo Biosciences

Senior Vice President, Head of Development

2021

R Ramelmeier

Sangamo Biosciences

Executive Vice President, Technical Operations

2021

D McClung

Sangamo Biosciences

Chief Operating Officer

2021

Sung Lee

Sangamo Biosciences

Chief Financial Officer

News

You may also like